PedAM
Pediatric Disease Annotations & Medicines
| Disease | maturity-onset diabetes of the young |
| Phenotype | C0011847|diabetes |
| Sentences | 6 |
| PubMedID- 23942200 | Other topics, such as cardiogenetics (ie, long qt syndrome or hyperthrophic cardiomyopathy) or diabetes (ie, maturity-onset diabetes of the young), could also be trained in this framework. |
| PubMedID- 21949805 | The intracellular signaling mechanisms regulating insulin secretion have been extensively studied [4], and transcription factors have been linked to β-cell dysfunction in type 2 diabetes and maturity-onset diabetes of the young [3], [5]. |
| PubMedID- 20938745 | Non-autoimmune type 1 diabetes (t1dm)), maturity-onset diabetes of the young (mody), and early-onset type 2 diabetes (t2dm) (figs. |
| PubMedID- 20863361 | Bmi: body mass index; gada: glutamic acid decarboxylase autoantibodies; iaa: insulin autoantibodies; ia-2a: insulinoma-associated antigen-2 autoantibodies; ica: islet cell antibodies; k-atp channel: atp-sensitive potassium channel; monogenic diabetes: maturity-onset diabetes of the young; ru: relative units. |
| PubMedID- 23761103 | Monogenic diabetes, or maturity-onset diabetes of the young (mody), is caused by mutations of these genes (hnf1α-mody, hnf1β-mody, pdx1-mody, neurod1-mody) (11–16). |
| PubMedID- 20682687 | Although pharmacogenetic investigation has yielded clinically actionable results in neonatal diabetes and maturity-onset diabetes of the young, extending these studies to common type 2 diabetes has been more arduous (2). |
Page: 1